Peter Ho

Researcher Profile 5/10

Cho Ray Hospital · Medicine and Pharmacy

68 publications · 2,826 citations · h-index 26

Information

🏛️Affiliation: Cho Ray Hospital
🔬Field: Medicine and Pharmacy
✍️Profile incomplete — add information

An h-index of 26 places this researcher in Medicine and Pharmacy, within the top 5% of 6,619 profiles in this field in our directory.

Featured publications

Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study621 citations
The Lancet Oncology · 2018 · DOI

Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016253 citations
Oncogene · 2004 · DOI

Regulatory Approvals of Pediatric Oncology Drugs: Previous Experience and New Initiatives228 citations
Journal of Clinical Oncology · 2003 · DOI

Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models172 citations
Molecular Cancer Therapeutics · 2017 · DOI

Phase I Dose Escalation and Pharmacokinetic Study of Lapatinib in Combination With Trastuzumab in Patients With Advanced ErbB2-Positive Breast Cancer119 citations
Journal of Clinical Oncology · 2008 · DOI

A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma118 citations
British Journal of Cancer · 2011 · DOI

Prenatal Detection of Neuroblastoma: A Ten-Year Experience From the Dana-Farber Cancer Institute and Children's Hospital110 citations
PEDIATRICS · 1993 · DOI

Final Report of Phase 1 Study of the DOT1L Inhibitor, Pinometostat (EPZ-5676), in Children with Relapsed or Refractory MLL-r Acute Leukemia89 citations
Blood · 2016 · DOI

Safety, tolerability and pharmacokinetics of oral administration of GW786034 in pts with solid tumors74 citations
Journal of Clinical Oncology · 2005 · DOI

A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose73 citations
Cancer Chemotherapy and Pharmacology · 2010 · DOI

About the field of Medicine and Pharmacy

6,619researchers 91,896publications 2,589,484citations 4.2average h-index

Common research topics in this field:

Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions

Institutions with the most researchers in this field: